Herbal Extract
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Saffron contains crocin and crocetin, carotenoids that protect retinal cells and improve macular function. Multiple RCTs show 20 mg/day improves visual acuity in early AMD within 3 months. It is one of the most promising emerging treatments for age-related macular degeneration.
Saffron is one of the most exciting emerging therapies for AMD. Falsini et al. (2010) demonstrated that 20 mg/day improved focal ERG amplitude and visual acuity in early AMD patients within 3 months. A follow-up 15-month study confirmed sustained benefits. Marangoni et al. (2013) showed saffron also improved macular function in Stargardt macular dystrophy. While study sizes remain small, the consistency of positive results across multiple trials is noteworthy.
Saffron is one of the most exciting emerging therapies for AMD.
| Form | Bioavailability | Best For |
|---|---|---|
| Standardized Saffron Extract (3% crocin) | Moderate | Clinical use — matches doses used in AMD clinical trials |
| Whole Saffron Stigma Supplement | Moderate | Whole-herb approach — contains full spectrum of saffron bioactives |
General recommendation: 20-30 mg saffron extract daily
Timing: Can be taken at any time of day; with or without food
| Condition | Recommended Dose | Evidence |
|---|---|---|
| Early AMD support | 20 mg daily | Emerging |
| Macular function | 20-30 mg daily | Emerging |
| Retinal neuroprotection | 20 mg daily | Preliminary |
Upper limit: 200 mg/day short-term has been tolerated; standard supplemental doses are 20-30 mg/day
Safety profile: Generally Safe
Multiple small but well-designed RCTs show saffron at 20 mg/day improves visual acuity and retinal electrical responses (ERG) in early AMD within 3 months. However, studies are still small (25-60 participants). It is best considered as a complementary approach alongside AREDS2 nutrients, not a replacement.
Clinical trials consistently use 20 mg of saffron extract per day. This is far more than culinary amounts (a typical recipe uses 0.5-1 mg). Dedicated saffron supplements standardized to crocin content are needed to achieve therapeutic doses.
No. Cooking uses 0.5-1 mg of saffron per dish, while clinical trials use 20 mg of standardized extract. You would need to consume enormous culinary quantities to match supplement doses. Additionally, heat may degrade some of the active crocin and crocetin compounds.